Italy’s exports to China have tripled in little more than a year. The problem is, even the experts are struggling to explain why.
Shipments abroad rose above 3 billion euros (US$3.3 billion) in February, up 131 percent from a year earlier. This follows another jump of 137 percent the month before.
For comparison, Italy exported about 1 billion euros of goods and services in January last year to the world’s No. 2 economy.
Photo: AP
Such a boom would be hard to explain under normal circumstances. Now, as Russia’s war in Ukraine and supply-chain upheaval distorts traditional trade flows, it is downright mysterious.
First, consider the politics. Italy might be the only G7 country that has signed up to China’s mammoth investment plan, the Belt and Road Initiative, but the economic benefits of such an alliance since 2019 have been limited.
Moreover, relations had already cooled significantly under former Italian prime minister Mario Draghi. His successor, Giorgia Meloni, has signaled to US officials that she would pull out of the controversial China deal before the end of the year.
What makes the data even more puzzling is that it is all down to a specific sector: pharmaceuticals. To be more precise, “medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses.”
Exports of this group of products rose to 1.84 billion euros in February from 98.5 million euros a year earlier. They accounted for almost two-thirds of all Italian exports to China.
Why the spike? Italian media have speculated that the driving force is runaway Chinese demand for ursodeoxycholic acid (UDCA), a chemical used mostly in liver drugs and that has been claimed — without reason — to help prevent COVID-19.
So the sudden end of China’s “zero COVID” strategy and the subsequent wildfire spread of the virus across the country might be behind the export boom, although the vast majority of China’s population appears to have gotten COVID-19 in December last year and January, meaning they would have recovered before Italian exports started rising.
However, UDCA demand alone does not explain the export peak.
Industria Chimica Emiliana Srl, the Italian company that is the world’s largest integrated producer of UDCA and bile acid products, has yearly sales of about 300 million euros, just a fraction of the jump in Italian pharma exports to China.
Adding to the uncertainty, the most recent Chinese data yields little evidence these products are arriving en masse. Considering shipping times, the drugs — whatever kind they are — should have made it to China to be counted in last month’s trade data, but there was no observable change.
One explanation might be shifting regional trade.
“It’s likely demand for medicines from China,” said Peter Ceretti, a director at Eurasia Group who investigated the matter. “Larger Italian pharma producers are shipping as much Italian-made product as they can, and perhaps some are moving German and other European Union-produced medicine into Italy for re-export to China, too.”
‘SWASTICAR’: Tesla CEO Elon Musk’s close association with Donald Trump has prompted opponents to brand him a ‘Nazi’ and resulted in a dramatic drop in sales Demonstrators descended on Tesla Inc dealerships across the US, and in Europe and Canada on Saturday to protest company chief Elon Musk, who has amassed extraordinary power as a top adviser to US President Donald Trump. Waving signs with messages such as “Musk is stealing our money” and “Reclaim our country,” the protests largely took place peacefully following fiery episodes of vandalism on Tesla vehicles, dealerships and other facilities in recent weeks that US officials have denounced as terrorism. Hundreds rallied on Saturday outside the Tesla dealership in Manhattan. Some blasted Musk, the world’s richest man, while others demanded the shuttering of his
TIGHT-LIPPED: UMC said it had no merger plans at the moment, after Nikkei Asia reported that the firm and GlobalFoundries were considering restarting merger talks United Microelectronics Corp (UMC, 聯電), the world’s No. 4 contract chipmaker, yesterday launched a new US$5 billion 12-inch chip factory in Singapore as part of its latest effort to diversify its manufacturing footprint amid growing geopolitical risks. The new factory, adjacent to UMC’s existing Singapore fab in the Pasir Res Wafer Fab Park, is scheduled to enter volume production next year, utilizing mature 22-nanometer and 28-nanometer process technologies, UMC said in a statement. The company plans to invest US$5 billion during the first phase of the new fab, which would have an installed capacity of 30,000 12-inch wafers per month, it said. The
MULTIFACETED: A task force has analyzed possible scenarios and created responses to assist domestic industries in dealing with US tariffs, the economics minister said The Executive Yuan is tomorrow to announce countermeasures to US President Donald Trump’s planned reciprocal tariffs, although the details of the plan would not be made public until Monday next week, Minister of Economic Affairs J.W. Kuo (郭智輝) said yesterday. The Cabinet established an economic and trade task force in November last year to deal with US trade and tariff related issues, Kuo told reporters outside the legislature in Taipei. The task force has been analyzing and evaluating all kinds of scenarios to identify suitable responses and determine how best to assist domestic industries in managing the effects of Trump’s tariffs, he
Taiwan’s official purchasing managers’ index (PMI) last month rose 0.2 percentage points to 54.2, in a second consecutive month of expansion, thanks to front-loading demand intended to avoid potential US tariff hikes, the Chung-Hua Institution for Economic Research (CIER, 中華經濟研究院) said yesterday. While short-term demand appeared robust, uncertainties rose due to US President Donald Trump’s unpredictable trade policy, CIER president Lien Hsien-ming (連賢明) told a news conference in Taipei. Taiwan’s economy this year would be characterized by high-level fluctuations and the volatility would be wilder than most expect, Lien said Demand for electronics, particularly semiconductors, continues to benefit from US technology giants’ effort